Non-Mammalian cDNA
Genscript Corporation CD27/TNFRSF7 hFc ChimeraBioti
CD27 also known as TNFRSF7 is an approximately 55 kDa transmembrane protein in the TNF receptor superfamily It functions as a co stimulatory molecule that supports lymphocyte activation and survival It binds to ligand CD70 and plays a key role in regulating B-cell activation and immunoglobulin synthesis
Bioss Somatostatin Receptor 1 Recomb
Somatostatin Receptor 1 Primary Antibody Unconjugated Host Species Rabbit Target Species Human Clonality Monoclonal Applications WB IF(ICC) RecombinantConcentration 1ug/ul Size 100 ul Storage Buffer 10mM phosphate buffered saline(pH 7 4) with 150mM sodium chloride 0 05% BSA 0 02% sodium azide and 50% glycerol
Cayman Chemical 5-IPF2a-VI 10ug
A psychoactive analog of p-iodoamphetamine that is indistinguishable in its physiological effects from MDMA in rats significantly reduces both serotonin uptake sites and hippocampal serotonin levels in rats intended for forensic applications
Genscript Corporation Fc gamma RIIIA/CD16a V176 Do
Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG Binds complexed or aggregated IgG and also monomeric IgG Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses such as phagocytosis
Abcam alpha-Methyl 5-hydro x ytryptamine maleate, 5-HT2A/2C receptor agonist, 50MG
MW 306.32 g/mol, Purity >99%. 5-HT₂A/₂C receptor agonist (Ki values are 4.6 and 8.3 nM, respectively in human receptors). Potent antinociceptive effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 699551 dihydrochloride, 5-HT5A receptor antagonist, 50MG
MW 584.66 g/mol, Purity >98%. Selective 5-HT₅A receptor antagonist (pKi values are 8.3, for 5-HT₅A and < 6.0 for 5-HT₁B/D, 5-HT₂A, 5-HT₂C, 5-HT₁A and 5-HT₇ receptors). Increases extracellular 5-HT levels.
The product is subject to the following: Abcam Restricted Use Statement
Biotium Primary Antibody CD20 109-3C2 CF740 1/EA
Recognizes a protein of 30-33 kDa which is identified as CD20 (Workshop V Code CD20 12 Workshop IV Code B17) It recognizes an extracellular domain of CD20 It is a non-Ig differentiation antigen of B-cells and its expression is restricted to normal and neoplastic B-cells being absent from all other leukocytes and tissues CD20 is expressed by pre B-cells and persists during all stages of B-cell maturation but is lost upon terminal differentiation into plasma cells The protein passes through the membrane 4 times with both ends in cytoplasm and exposes one short and one longer loop to the external environment CD20 is not glycosylated in resting B-cells and its cytoplasmic domains are differentially phosphorylated upon activation It acts as calcium channel involved in B cell activation and cell cycle progression Primary antibodies are available purified or with a selection of fluorescent CF Dyes and other labels CF Dyes offer exceptional brightness and photostability Note Conjugates of
Abcam NAN-190 hydrobromide, 5-HT1A antagonist, 50MG
MW 474.4 g/mol, Purity >99%. Potent 5-HT₁A receptor antagonist (Ki = 6.8 nM). Also displays activity at α₂ adrenoceptors. Displays anxiogenic and anxiolytic effects. Additionally, potentiates circadian rhythm response to light.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical AdenosIn A2A Receptrhumn 10ug
Source: N-terminal his- and strep-tagged human adenosine A2A receptor containing a TEV protease cleavage site purified from a baculovirus overexpression system in Sf9 cells • MW = ~47.7 kDa
Abcam SB 204741, 5-HT2B receptor antagonist, 10MG
MW 286.35 g/mol, Purity >99%. Selective 5-HT₂B receptor antagonist. High affinity for 5-HT₂B receptors (pKi = 7.85), some activity at 5-HT₂C receptors (pKi = 5.8).
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 269970 hydrochloride, 5-HT7 receptor antagonist, 50MG
MW 389 Da, Purity >98%. Potent, selective 5-HT7 receptor antagonist (pKi values are 8.3, 7.2 and 6.0 for 5-HT7A, 5-HT5A and 5-HT1B receptors, respectively). Also potently blocks α2 adrenoceptors. Blocks amphetamine and ketamine induced hyperactivity. Brain penetrant *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 204741, 5-HT2B receptor antagonist, 50MG
MW 286.35 g/mol, Purity >99%. Selective 5-HT₂B receptor antagonist. High affinity for 5-HT₂B receptors (pKi = 7.85), some activity at 5-HT₂C receptors (pKi = 5.8).
The product is subject to the following: Abcam Restricted Use Statement